WallStreetZenWallStreetZen

NASDAQ: PTCT
Ptc Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PTCT past revenue growth

How has PTCT's revenue growth performed historically?
Company
20.39%
Industry
144.63%
Market
17.55%
PTCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PTCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PTCT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PTCT earnings and revenue history

Current Revenue
$927.6M
Current Earnings
-$579.2M
Current Profit Margin
-62.4%

PTCT Return on Equity

Current Company
N/A
Current Industry
-18.4%
Current Market
28.2%

Be the first to know when PTCT announces earnings.

PTCT Return on Assets

Current Company
-36.9%
Current Industry
0.7%
PTCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PTCT Return on Capital Employed

Current Company
-41.41%
Current Industry
13.8%
PTCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PTCT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PTCT$927.56M-$245.30M-$579.22M+28.74%N/A
ARVN$78.50M-$359.70M-$367.30M+40.53%N/A
VERA$0.00-$94.07M-$95.99MN/AN/A
VCEL$197.52M$8.93M-$3.18M+16.80%N/A
DNLI$330.53M-$128.47M-$145.22M+20.67%N/A
View Top Biotech Stocks

PTCT earnings dates

Next earnings date
Jun 5, 2024

Ptc Therapeutics Earnings & Revenue FAQ

What were PTCT's earnings last quarter?

On Invalid Date, Ptc Therapeutics (NASDAQ: PTCT) reported Q1 2024 earnings per share (EPS) of -$1.20, up 36.17% year over year. Total Ptc Therapeutics earnings for the quarter were -$91.58 million. In the same quarter last year, Ptc Therapeutics's earnings per share (EPS) was -$1.88.

If you're new to stock investing, here's how to buy Ptc Therapeutics stock.

What was PTCT's earnings growth in the past year?

As of Q2 2024, Ptc Therapeutics's earnings has grown year over year. Ptc Therapeutics's earnings in the past year totalled -$579.22 million.

What is PTCT's earnings date?

Ptc Therapeutics's earnings date is Invalid Date. Add PTCT to your watchlist to be reminded of PTCT's next earnings announcement.

What was PTCT's revenue last quarter?

On Invalid Date, Ptc Therapeutics (NASDAQ: PTCT) reported Q1 2024 revenue of $210.12 million up 4.66% year over year. In the same quarter last year, Ptc Therapeutics's revenue was $220.38 million.

What was PTCT's revenue growth in the past year?

As of Q2 2024, Ptc Therapeutics's revenue has grown 20.39% year over year. This is 124.24 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Ptc Therapeutics's revenue in the past year totalled $927.56 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.